Skip to main content
Journal of Oncology logoLink to Journal of Oncology
. 2019 Aug 21;2019:7921582. doi: 10.1155/2019/7921582

Corrigendum to “Outcomes of Programmed Cell Death Protein 1 (PD-1) and Programmed Death-Ligand 1 (PD-L1) Inhibitor Therapy in HIV Patients with Advanced Cancer”

Shahla Bari 1,, Jameel Muzaffar 2, Austin Chan 3, Sanjay R Jain 3, Ahmad M Haider 4, Marjorie Adams Curry 5, Christopher J Hostler 6
PMCID: PMC6719266  PMID: 31531021

In the article titled “Outcomes of Programmed Cell Death Protein 1 (PD-1) and Programmed Death-Ligand 1(PD-L1) Inhibitor Therapy in HIV Patients with Advanced Cancer” [1], Drs. Jameel Muzaffar, Ahmad M. Haider, and Marjorie Adams Curry were missing from the authors' list.

Dr. Jameel Muzaffar, MD, was responsible for manuscript guidance and preparation.

Dr. Ahmad M. Haider was responsible for statistical analysis and chart preparation.

Dr. Marjorie Adams Curry was responsible for providing partial list of patients who were treated with PDL1 inhibitors.

The corrected authors' list is shown above, and it has been added in-line to the published article.

References

  • 1.Bari S., Muzaffar J., Chan A., et al. Outcomes of programmed cell death protein 1 (PD-1) and programmed death-ligand 1(PD-L1) inhibitor therapy in HIV patients with advanced cancer. Journal of Oncology. 2019;2019:5. doi: 10.1155/2019/2989048.2989048 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Oncology are provided here courtesy of Wiley

RESOURCES